TP53 rs1625895 is Related to Breast Cancer Incidence and Early Death in Iranian Population.

Abstract

Breast cancer as the second most common cancer worldwide tend to be experienced by Iranian women 10 years earlier with a peak incidence at the premenopausal stage. Genetic mutations of TP53 tumor suppressor gene has been shown to be related to early onset of breast cancer. It has been shown already that rs1625895 polymorphic site is related to glioma as well as lung cancer. In this study, we have investigated the role of rs1625895 polymorphism in breast cancer incidence in Iranian women. DNA extraction of 86 breast cancer patients and 96 control individuals have been used for allele-specific primer-PCR and genotyping of allele A and allele G of the TP53 rs1625895. Genotypes frequencies have been shown that GG homozygosis as the most frequent genotype is a significant association with increased risk of breast cancer development in Iranian women (odds ratio = 6, p = 0.002). On the other hand and in comparison to allele G, allele A could cause early death of breast cancer patients by threefolds significantly (p = 0.011). As a conclusion, we show that allele A is the minor allele in both breast cancer patients and also control individuals and major allele G, is related to the increased risk of breast cancer development in Iranian women.

• Authors: Leila Assad Samani, Seyed-Morteza Javadirad, Soha Parsafar, Hossein Tabatabaeian, Kamran Ghaedi, Mansoureh Azadeh
• Journal: Indian journal of clinical biochemistry : IJCB (Indian J Clin Biochem) Vol. 34 Issue 4 Pg. 485-489 (Oct 2019) ISSN: 0970-1915 [Print] India
• PMID: 31686737 (Publication Type: Journal Article)
• Copyright: © Association of Clinical Biochemists of India 2018.